An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Recruiting · NCT06634849 · Registry updated 2026-02-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1). | neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-02-10 | NCT06634849 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pathios Therapeutics Pty Ltd | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Austin Health | Heidelberg | Australia | 70 |
| Blacktown Hospital | Blacktown | Australia | 18 |
| Linear Clinical Research | Nedlands | Australia | 23 |
| Scientia Clinical Research | Randwick | Australia | 20 |
| Southern Oncology Clinical Research Unit (SOCRU) | Adelaide | Australia | 1 |